Florida Tobacco Revenue Lower Than Expected

Aug.10.2022
Florida Tobacco Revenue Lower Than Expected
Smoking decline may reduce Florida's tobacco industry revenue as the state receives less than expected settlement payments.

Source: JF19


According to a report by The Free Press, the state of Florida may receive lower-than-expected revenue from the tobacco industry due to a decrease in the number of smokers and a decrease in the amount of tobacco consumed by remaining smokers.


In 1998, the largest tobacco company in the United States settled a lawsuit brought by state attorneys general over the costs of treating sick smokers. The tobacco industry agreed to pay billions of dollars over the course of more than 20 years, with the payment amount based on the quantity of cigarettes sold.


According to a report released on August 5th, economists are predicting that Florida will receive $412.1 million in settlement funds by the end of the year, which is lower than the previously estimated $413.8 million.


The report indicates that cigarette sales are predicted to decline by 2.5% annually over the next decade.


Previously, the projected decline was expected to be between 1.44% to 1.75%. The report also stated that payments made by tobacco manufacturers were $1.7 million less than expected for the recently completed 2021-2022 fiscal year.


During the state revenue estimation conference, economists also revised their projections for future payments over the next few years.


It was previously projected that the revenue for the 2023-2024 fiscal year would be $442.5 million, but now it is estimated that the state will obtain $417.9 million through a settlement during this period.


Statement:


This article is compiled from third-party information and is intended for industry professionals for communication and learning purposes.


This article does not represent the views of 2FIRSTS. 2FIRSTS is also unable to confirm the authenticity and accuracy of the article's contents. The translation of this article is only intended for industry exchange and research purposes.


Due to limitations in translation ability, translated articles may not fully express the intended meaning of the original text. Please refer to the original text for accuracy.


2FIRSTS is fully aligned with the Chinese government in regards to any domestic, Hong Kong, Macao, Taiwan, and foreign-related statements and positions.


The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

UK MHRA Watch | 200+ SKUs Listed in 10 Days: FUMOT Accounts for Nearly Half as ELFBAR and Others Roll Out New Products
UK MHRA Watch | 200+ SKUs Listed in 10 Days: FUMOT Accounts for Nearly Half as ELFBAR and Others Roll Out New Products
From July 9 to 18, brands including ELFBAR, GEEKVAPE, and FUMOT submitted over 200 e-cigarette SKUs for public listing with the UK Medicines and Healthcare products Regulatory Agency (MHRA), featuring high-puff devices, refillable pods, and multi-flavor compatible cartridges.
Jul.18 by 2FIRSTS.ai
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
The U.S. FDA will review Philip Morris International’s renewal application for five IQOS products' modified risk status at an October 7 TPSAC meeting, evaluating whether they still meet the required standards.
Jul.30 by 2FIRSTS.ai
2Firsts Interview with Alchem: Addressing Quality, Speed, and Regulation in Next-Gen Nicotine Solutions
2Firsts Interview with Alchem: Addressing Quality, Speed, and Regulation in Next-Gen Nicotine Solutions
As global regulations tighten and demand for smoke-free alternatives grows, the nicotine industry is rapidly evolving. In an interview with 2Firsts, Alchem discusses how enhanced purity, consistency, and technological innovation help address quality, speed, and compliance challenges.
Jul.10
Ireland to Ban Flavored E-Cigarettes, Advertising; Industry Warns 220,000 Vapers at Risk
Ireland to Ban Flavored E-Cigarettes, Advertising; Industry Warns 220,000 Vapers at Risk
Ireland plans to ban flavored e-cigarettes, introduce plain packaging, and restrict in-store displays and advertising. The Responsible Vaping Ireland group warns the move could harm small businesses and reverse progress in reducing smoking. Since 2015, over 225,000 adults have quit smoking with e-cigarettes, making up nearly a quarter of quitters in 2023.
Jun.03 by 2FIRSTS.ai
Smoore International Issues 2025 Interim Profit Warning: First-Half Earnings Expected to Drop 21%–35% YoY
Smoore International Issues 2025 Interim Profit Warning: First-Half Earnings Expected to Drop 21%–35% YoY
Smoore International has issued a profit warning, expecting net profit for the six months ended June 30, 2025, to decline by approximately 21% to 35% year-on-year, projected to range between 443 million and 541 million yuan.
Jul.16 by 2FIRSTS.ai
Ireland Finds "Nicotine-Free" E-Cigarettes Contain Nicotine; Involves McKesse, JNR, and Crystal Brands
Ireland Finds "Nicotine-Free" E-Cigarettes Contain Nicotine; Involves McKesse, JNR, and Crystal Brands
Ireland’s HSE found some “nicotine-free” e-cigarettes contain nicotine, misleading consumers and risking addiction. The products were seized, and a warning issued. Experts warn nicotine addiction is underestimated, and health impacts remain unclear.
Aug.01 by 2FIRSTS.ai